Blawg Search - Law Blogs, Lawyer Blogs, Legal Blogs Directory & Search Engine

... & Gamble Co. (P&G), relates to the compound risedronate, which is the active ingredient in P&G's osteoporosis drug Actonel®. Risedronate is a member of a class of compounds known as bisphosphonates, which are active in inhibiting bone resorption. After Defendant-Appellant Teva Pharmaceuticals USA, Inc. notified P&G of its intent to market a generic version of...

By Kevin E. Noonan -- On Friday, the Court of Appeals for the Federal Circuit handed Pfizer a mixed decision on defendant Teva's appeal of a District Court judgment that Teva was liable for infringing a trio of Pfizer patents (U.S. Patent Nos. 5,466,823; 5,563,165; and 5,760,068) relating to the...

... omission and those of commission. In patent law, inequitable conduct comes closest to this concept of sin, where frequently the accused behavior is the failure to submit to a patent examiner during prosecution information that is material to patentability. However, mere failure to submit is not enough; there must be some evidence of deceptive intent. Kingsdown Medical Consultants, Ltd. v. Hollister Inc., 863 F.2d 867 (Fed. Cir. 1988) (en banc). These principles were reaffirmed last Friday by...

... is excerpted from a Thursday, July 02, 2009 press release at Webwire: Bayer Schering Pharma AG, Germany and Bayer HealthCare Pharmaceuticals Inc. together with Schering Corporation have filed a patent infringement lawsuit in the U.S. Federal Court in the District of Delaware against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd.. The lawsuit concerns Teva's application to the FDA for approval to market ...

... its declaratory judgment jurisdiction jurisprudence ever since the Supreme Court's Medimmune, Inc. v. Genentech, Inc. decision. These cases have included SanDisk Corp. v. STMicroelectronics, Inc., Teva Pharmaceuticals USA, Inc. v. Novartis Pharmaceuticals Corp., Benitec Australia, Ltd. v. Nucleonics, Inc., ... . The trend continues, albeit in a nonprecedential opinion, in Merck & Co. v. Apotex Inc. In a per curiam decision from a panel made up of CAFC Judges Mayer and Linn and ...

... a bench trial concerning Merck's Singulair® patent, the court rejected Teva Pharmaceutical's validity and unenforceability defenses and concluded that Teva's ANDA applications infringed the patent-in-suit. "[T]he Court . . . concludes that Teva has failed to prove either that: (1) [Merck] acquired the '473 patent through inequitable conduct or ( ... -22 of the '473 patent." Merck Sharp & Dohme Pharm. SRL v. Teva Pharm. USA, Inc. et al., 3-07-cv-01596 (NJD August 19, 2009, ...

... - Office of the National General Attorney issues opinion stating on dual analysis system for pharmaceutical inventions (Koury Lopes Advogados) EU: Bundesgerichtshof refers human stem cell patent ... suit commenced in response to Paragraph IV certification: Eurand Inc. et al. v. Teva Pharmaceuticals USA, Inc. et al (Patent Docs) Carbatrol (Carbamazepine) ... response to Paragraph IV certification - Novartis AG et al. v. Apotex Inc. et al. (Patent Docs) Prandimet (Repaglinide and Metformin) - US: Patent ...

... . 7:09-113 Eastern District of Pennsylvania Steven Rosenfeld v. Teva Pharmaceuticals USA, Inc., et al., C.A. No. 2:09-2811 Northern District ... : PLASMA-DERIVATIVE PROTEIN THERAPIES ANTITRUST LITIGATION Motion of plaintiff Hospital Damas, Inc., for centralization of the following actions in the United States District Court for the Northern District of Illinois: ... States district court: District of District of Columbia Laura Brooks v. Novartis Pharmaceuticals Corp., et al., C.A. No. 1:08-484 Dara Pace ...

... the number of patent infringement lawsuits involving life-sciences technologies (e.g., pharmaceuticals, biologics, and medical devices). In 2006, 21 plaintiffs filed 23 patent infringement ... MD, company that specializes in nutritional supplements, and Israel's Teva Pharmaceutical Industries, Inc. (with its Teva Pharmaceuticals USA, Inc., subsidiary), both of which filed two patent ... et al v. Automotive Lifts & Machinery Corp. Plastic Safety Systems, Inc. v. Road Safety, LLC et al STX, L.L.C. v ...

... - Office of the National General Attorney issues opinion stating on dual analysis system for pharmaceutical inventions (Koury Lopes Advogados) EU: Bundesgerichtshof refers human stem cell patent ... suit commenced in response to Paragraph IV certification: Eurand Inc. et al. v. Teva Pharmaceuticals USA, Inc. et al (Patent Docs) Carbatrol (Carbamazepine) ... response to Paragraph IV certification - Novartis AG et al. v. Apotex Inc. et al. (Patent Docs) Prandimet (Repaglinide and Metformin) - US: Patent ...